Policy framework for rare disease health disparities

Policy, Politics, and Nursing Practice

Volumn 12, Issue 2, 2011, Pages 114-118

  Williams, Pamela Holtzclaw ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

health disparity; policy; Rare Diseases

Indexed keywords

ARTICLE; DRUG MANUFACTURE; HEALTH CARE DISPARITY; HEALTH CARE POLICY; HUMAN; LEGAL ASPECT; PSYCHOLOGICAL ASPECT; PUBLIC OPINION; RARE DISEASE; UNITED STATES;

HEALTH POLICY; HEALTHCARE DISPARITIES; HUMANS; ORPHAN DRUG PRODUCTION; PUBLIC OPINION; RARE DISEASES; UNITED STATES;

EID: 80055105320     PISSN: 15271544     EISSN: 15527468     Source Type: Journal    
DOI: 10.1177/1527154411404243     Document Type: Article

References (25)

1. Aubeeluck A.,Moskowitz C. B.Huntington's disease. Part 3: Family aspects of HD.British Journal of Nursing. 2008;17:328-331.
2. Brewer G. J.Drug development for orphan diseases in the context of personalized medicine.Translational Research. 2009;154:314-322.
3. Brewer H. M.,Eatough V.,Smith J. A.,Stanley C. A.,Glendinning N. W.,Quarrell O. W. J.The impact of juvenile Huntington's disease on the family: The case of a rare childhood condition.Journal of Health Psychology. 2008;13 (1): 5-16.
4. Clifton J. M.,VanBeuge S. S.,Mladenka C.,Wosnik K. K.The Genetic Information Nondiscrimination Act 2008: What clinicians should understand.Journal of the American Academy of Nurse Practitioners. 2010;22:246-249.
5. Cohen J.,Biesecker B.Quality of life in rare genetic conditions: A systematic review of the literature.American Journal of Medical Genetics Part A, 152A. 2010;:1136-1156.
6. Dellve L.,Samuelsson L.,Tallborn A.,Fasth A.,Hallberg L. R. M.Stress and well-being among parents of children with rare diseases: A prospective intervention study.Journal of Advanced Nursing. 2006;53:392-402.
7. Genetic Information Nondiscrimination Act of 2008, Pub. L. No. 110-233 (2008).
8. Griggs R. C.,Batshaw M.,Dunkle M.,Gopal-Srivastava R.,Kaye E.,Krischer J.,Merkel P. A.Clinical research for rare disease: Opportunities, challenges, and solutions.Molecular Genetics and Metabolism. 2009;96 (1): 20-26.
9. Hampton T.Rare disease research gets boost.Journal of the American Medical Association. 2006;295:2836-2838.
10. Huyard C.What, if anything, is specific about having a rare disorder? Patients' judgements on being ill and being rare.Health Expectations. 2009;12:361-370.
11. Kruer M. C.,Steiner R. D.The role of evidence-based medicine and clinical trials in rare genetic disorders.Clinical Genetics. 2008;74:197-207.
12. McGuire A.,Majumder M.Two cheers for GINA?.Genome Medicine. 2009;1 (1): 6.
13. Minority Health and Health Disparities Research and Education Act of 2000, Pub. L. No. 106-525 (2000).
14. Orphan Drug Act, Pub. L. No. 97-414 (1983).
15. Penziner E.,Williams J.,Erwin C.,Bombard Y.,Wallis A.,Beglinger L.Paulsen J. S.Perceptions of discrimination among persons who have undergone predictive testing for Huntington's disease.American Journal of Medical Genetics Part B (Neuropsychiatric Genetics), 147B. 2008;:320-325.
16. Rare Diseases Act, Pub. L. No. 107-280 (2002).
17. Rare Diseases Orphan Product Development Act of 2002, Pub. L. No. 107-281 (2002).
18. Remuzzi G.,Garrattini S.Rare diseases: What's next?.Lancet. 2008;371:1978-1979.
19. Scheindlin S.Rare diseases, orphan drugs, and orphaned patients.Molecular Interventions. 2006;6:186-191.
20. Schieppati A.,Henter J.-I.,Daina E.,Aperia A.Why rare diseases are an important medical and social issue.Lancet. 2008;371:2039-2041.
21. Schlander M.,Beck M.Expensive drugs for rare disorders: To treat or not to treat? The case of enzyme replacement therapy for mucopolysaccharidosis VI.Current Medical Research and Opinion. 2009;25:1285-1293.
22. Shelly L. H.,Wendy P.,Seymour P.Psychosocial aspects of patients with Niemann-Pick disease, type B.American Journal of Medical Genetics Part A, 149A. 2009;:2430-2436.
23. US SenateOrphan Product Development Act of 2002. 2002Public Law No: 107-281.
24. US Senate Rare Diseases Act of 2002. 2002Public Law No: 107-280.
25. Watson M.,Epstein C.,Howell R. R.,Jones M.,Korf B. R.,McCabe E.,Simpson J. L.Developing a national collaborative study system for rare genetic diseases.Genetics in Medicine. 2008;10:325-329.